Capital Fund Management S.A. Blueprint Medicines Corp Put Options Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$84.1 - $120.5 $958,739 - $1.37 Million
11,400 Added 61.62%
29,900 $2.76 Million
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $630,332 - $804,972
7,400 Added 66.67%
18,500 $1.99 Million
Q1 2024

May 15, 2024
SELL
$73.17 - $99.79 $226,827 - $309,349
-3,100 Reduced 21.83%
11,100 $1.05 Million
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $624,232 - $1.32 Million
14,200 New
14,200 $1.31 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email